A magnetic vehicle realized tumor cell-targeted radiotherapy using low-dose radiation

Hsiao Ping Chen, Fu I. Tung, Ming Hong Chen, Tse Ying Liu

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Radiotherapy, a common cancer treatment, often adversely affects the surrounding healthy tissue and/or cells. Some tumor tissue-focused radiation therapies have been developed to lower radiation-induced lesion formation; however, achieving tumor cell-targeted radiotherapy (i.e., precisely focusing the radiation efficacy to tumor cells) remains a challenge. In the present study, we developed a novel tumor cell-targeted radiotherapy, named targeted sensitization-enhanced radiotherapy (TSER), that exploits tumor-specific folic acid-conjugated carboxymethyl lauryl chitosan/superparamagnetic iron oxide (FA-CLC/SPIO) micelles to effectively deliver chlorin e6 (Ce6, a sonosensitizer) to mitochondria of HeLa cells under magnetic guidance. For the in vitro tests, the sensitization of Ce6 induced by ultrasound, that could weaken the radiation resistant ability of tumor cells, occurred only in Ce6-internalizing tumor cells. Therefore, low-dose X-ray irradiation, that was not harmful to normal cells, could exert high tumor cell-specific killing ability. The ratio of viable normal cells to tumor cells was increased considerably, from 7.8 (at 24 h) to 97.1 (at 72 h), after they had received TSER treatment. Our data suggest that TSER treatment significantly weakens tumor cells, resulting in decreased viability in vitro as well as decreased in vivo subcutaneous tumor growth in nude mice, while the adverse effects were minimal. Taken together, TSER treatment appears to be an effective, clinically feasible tumor cell-targeted radiotherapy that can solve the problems of traditional radiotherapy and photodynamic therapy.

Original languageEnglish
Pages (from-to)182-192
Number of pages11
JournalJournal of Controlled Release
Volume226
DOIs
Publication statusPublished - Mar 28 2016
Externally publishedYes

Fingerprint

Radiotherapy
Radiation
Neoplasms
Photochemotherapy
Micelles
Therapeutics
HeLa Cells
Folic Acid
Nude Mice
Mitochondria
X-Rays
Growth

Keywords

  • Chlorin e6
  • Drug vehicle
  • Magnetic guidance
  • Targeted delivery
  • Tumor cell-targeted radiotherapy

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

A magnetic vehicle realized tumor cell-targeted radiotherapy using low-dose radiation. / Chen, Hsiao Ping; Tung, Fu I.; Chen, Ming Hong; Liu, Tse Ying.

In: Journal of Controlled Release, Vol. 226, 28.03.2016, p. 182-192.

Research output: Contribution to journalArticle

@article{7a48ac85748847bebbf175a678ea8a7c,
title = "A magnetic vehicle realized tumor cell-targeted radiotherapy using low-dose radiation",
abstract = "Radiotherapy, a common cancer treatment, often adversely affects the surrounding healthy tissue and/or cells. Some tumor tissue-focused radiation therapies have been developed to lower radiation-induced lesion formation; however, achieving tumor cell-targeted radiotherapy (i.e., precisely focusing the radiation efficacy to tumor cells) remains a challenge. In the present study, we developed a novel tumor cell-targeted radiotherapy, named targeted sensitization-enhanced radiotherapy (TSER), that exploits tumor-specific folic acid-conjugated carboxymethyl lauryl chitosan/superparamagnetic iron oxide (FA-CLC/SPIO) micelles to effectively deliver chlorin e6 (Ce6, a sonosensitizer) to mitochondria of HeLa cells under magnetic guidance. For the in vitro tests, the sensitization of Ce6 induced by ultrasound, that could weaken the radiation resistant ability of tumor cells, occurred only in Ce6-internalizing tumor cells. Therefore, low-dose X-ray irradiation, that was not harmful to normal cells, could exert high tumor cell-specific killing ability. The ratio of viable normal cells to tumor cells was increased considerably, from 7.8 (at 24 h) to 97.1 (at 72 h), after they had received TSER treatment. Our data suggest that TSER treatment significantly weakens tumor cells, resulting in decreased viability in vitro as well as decreased in vivo subcutaneous tumor growth in nude mice, while the adverse effects were minimal. Taken together, TSER treatment appears to be an effective, clinically feasible tumor cell-targeted radiotherapy that can solve the problems of traditional radiotherapy and photodynamic therapy.",
keywords = "Chlorin e6, Drug vehicle, Magnetic guidance, Targeted delivery, Tumor cell-targeted radiotherapy",
author = "Chen, {Hsiao Ping} and Tung, {Fu I.} and Chen, {Ming Hong} and Liu, {Tse Ying}",
year = "2016",
month = "3",
day = "28",
doi = "10.1016/j.jconrel.2016.02.025",
language = "English",
volume = "226",
pages = "182--192",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - A magnetic vehicle realized tumor cell-targeted radiotherapy using low-dose radiation

AU - Chen, Hsiao Ping

AU - Tung, Fu I.

AU - Chen, Ming Hong

AU - Liu, Tse Ying

PY - 2016/3/28

Y1 - 2016/3/28

N2 - Radiotherapy, a common cancer treatment, often adversely affects the surrounding healthy tissue and/or cells. Some tumor tissue-focused radiation therapies have been developed to lower radiation-induced lesion formation; however, achieving tumor cell-targeted radiotherapy (i.e., precisely focusing the radiation efficacy to tumor cells) remains a challenge. In the present study, we developed a novel tumor cell-targeted radiotherapy, named targeted sensitization-enhanced radiotherapy (TSER), that exploits tumor-specific folic acid-conjugated carboxymethyl lauryl chitosan/superparamagnetic iron oxide (FA-CLC/SPIO) micelles to effectively deliver chlorin e6 (Ce6, a sonosensitizer) to mitochondria of HeLa cells under magnetic guidance. For the in vitro tests, the sensitization of Ce6 induced by ultrasound, that could weaken the radiation resistant ability of tumor cells, occurred only in Ce6-internalizing tumor cells. Therefore, low-dose X-ray irradiation, that was not harmful to normal cells, could exert high tumor cell-specific killing ability. The ratio of viable normal cells to tumor cells was increased considerably, from 7.8 (at 24 h) to 97.1 (at 72 h), after they had received TSER treatment. Our data suggest that TSER treatment significantly weakens tumor cells, resulting in decreased viability in vitro as well as decreased in vivo subcutaneous tumor growth in nude mice, while the adverse effects were minimal. Taken together, TSER treatment appears to be an effective, clinically feasible tumor cell-targeted radiotherapy that can solve the problems of traditional radiotherapy and photodynamic therapy.

AB - Radiotherapy, a common cancer treatment, often adversely affects the surrounding healthy tissue and/or cells. Some tumor tissue-focused radiation therapies have been developed to lower radiation-induced lesion formation; however, achieving tumor cell-targeted radiotherapy (i.e., precisely focusing the radiation efficacy to tumor cells) remains a challenge. In the present study, we developed a novel tumor cell-targeted radiotherapy, named targeted sensitization-enhanced radiotherapy (TSER), that exploits tumor-specific folic acid-conjugated carboxymethyl lauryl chitosan/superparamagnetic iron oxide (FA-CLC/SPIO) micelles to effectively deliver chlorin e6 (Ce6, a sonosensitizer) to mitochondria of HeLa cells under magnetic guidance. For the in vitro tests, the sensitization of Ce6 induced by ultrasound, that could weaken the radiation resistant ability of tumor cells, occurred only in Ce6-internalizing tumor cells. Therefore, low-dose X-ray irradiation, that was not harmful to normal cells, could exert high tumor cell-specific killing ability. The ratio of viable normal cells to tumor cells was increased considerably, from 7.8 (at 24 h) to 97.1 (at 72 h), after they had received TSER treatment. Our data suggest that TSER treatment significantly weakens tumor cells, resulting in decreased viability in vitro as well as decreased in vivo subcutaneous tumor growth in nude mice, while the adverse effects were minimal. Taken together, TSER treatment appears to be an effective, clinically feasible tumor cell-targeted radiotherapy that can solve the problems of traditional radiotherapy and photodynamic therapy.

KW - Chlorin e6

KW - Drug vehicle

KW - Magnetic guidance

KW - Targeted delivery

KW - Tumor cell-targeted radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84958957847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958957847&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2016.02.025

DO - 10.1016/j.jconrel.2016.02.025

M3 - Article

C2 - 26892750

AN - SCOPUS:84958957847

VL - 226

SP - 182

EP - 192

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -